Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Impairment of the carnitine/organic cation transporter 1ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease
PT-141 may not be appropriate to use with every medication, supplement, or therapy
26 - Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)
This metabolic shift improves muscular endurance, reduces the heavy, burning sensation associated with minimal exertion, and helps patients expand their energy envelope
US$ 27.33
US$ 23.76
US$ 24.11
US$ 29.55
US$ 22.44
US$ 19.98
